SRC and lung cancer: Lung cancer signal transduction and cell growth proteins, namely cyclin-dependent kinase-2 (PDBID: 1AQ1), SRC-2 domains of C-ABL (PDBID: 1AB2), epidermal growth factor and receptor extracellular domains (PDBID: 1IVO), insulin-like growth factor-1 receptor kinase (PDBID: 1K3A) were docked with DrugBank compounds and identified 3-1-BCMIYPPA as multitargeted inhibitor for all the proteins.